Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

Sterling to buy Canadian drug plant

03-Dec-2009 - Australia’s Sterling Products plans to buy a 4,310 sqm pharmaceutical manufacturing plant from a Canadian drugmaker that has fallen victim to the global economic crisis.

News in brief

Merck & Co to close NJ warehouse with loss of 80 jobs

26-Nov-2009 - US drugmaker Merck & Co is to close a New Jersey warehouse owned by recent acquisition Schering-Plough, cutting 80 jobs.

Millipore buys Indian JV

24-Nov-2009 - Millipore has acquired the remaining 60 per cent of its Indian joint venture (JV) to drive growth in the country which it views, along with the other BRICS nations, as...

Emergent buys Baltimore production plant

17-Nov-2009 - US biotech Emergent BioSolutions has bought a manufacturing facility from Maryland’s MdBio Foundation is a bid to expand its production infrastructure.

Six Pfizer-Wyeth R&D sites to close post merger

10-Nov-2009 - Pfizer will close six R&D facilities in the US and the UK, reducing its global capacity by over a third following completion of its acquisition of Wyeth.

News in brief

New Jersey R&D sites vital, says Merck CEO

05-Nov-2009 - US R&D facilities in Rahway and Kenilworth, New Jersey will remain operational as they are vital to the to the newly formed Merck Schering-Plough group, according to CEO Richard Clark....

Lonza cuts 2009 guidance 14% and plans workforce cuts

02-Nov-2009 - Lonza cuts 2009 earning guidance and may reduce its workforce under “Project Bond” cost cutting plan after a Q3 characterized by an “accumulation of unexpected events”

IMS Health looking at buyout bids

22-Oct-2009 - IMS Health has confirmed it is “exploring strategic alternatives” after speculation this week suggested that the market analysis group had received a number of takeover bids.

Lonza withdraws Patheon bid, but still keen on CMOs

20-Oct-2009 - Swiss healthcare services giant Lonza has withdrawn its offer for Canadian CMO Patheon, citing value considerations, rejection of the bid by JLL and the availability of alternatives.

H Lundbeck eschews outsourcing and buys Elaiapharm

20-Oct-2009 - CNS focused drugmaker H Lundbeck says its acquisition of French CMO Elaiapharm represents a cheaper option than third-party manufacturing.

News in brief

Lilly sells Tippecanoe API site to Evonik

15-Oct-2009 - US drugmaker Eli Lilly will sell its Tippecanoe laboratories API manufacturing unit to Germany’s Evonik Industries.

Lonza builds in India in Simbiosys deal; updates on Patheon takeover

15-Oct-2009 - Lonza says that to the Indian market was a key motivation for its acquisition of Simbiosys Biowares India preclinical cell and molecular biology assets.

CPhI 2009 show preview

08-Oct-2009 - We look ahead to CPhI 2009 which takes place in Madrid, Spain next week and will showcase the world’s leading ingredients, contract services, machinery and biotech companies.

MannKind’s shares tumble; deal unlikely in 2009

07-Oct-2009 - MannKind’s share price tumbled by 31 per cent yesterday, just days after it published encouraging safety data for Afresa, because it revealed a partnership deal is unlikely to occur in 2009.

French govt unlikey to relinquish grip on health spending, says BMI

06-Oct-2009 - Despite the government’s “aggressive” promotion of generic drugs, pharmaceutical spending in France will continue to grow, according to new analysis by Business Monitor International (BMI).

Hospira buys facility & filgrastim rights to boost biogenerics

06-Oct-2009 - Hospira has acquired the worldwide rights to filgrastim and a Croatian biologics plant from Pliva, increasing its presence in the biogenerics field, and told in-PharmaTechnologist that further expansions are possible.

Sun says Taro suit is “baseless litigation”

01-Oct-2009 - Sun Pharmaceuticals says the new lawsuit filed against it by Taro Pharmaceuticals is “another unfortunate attempt by the Taro directors to divert Taro's limited resources to assisting the Levitt family...

News in brief

J&J buys 18% of Crucell

29-Sep-2009 - US health care major J&J has paid €302m for an 18 per cent stake in Dutch biotechnology Crucell and announced plans for a collaborative drug development programme.

Breaking news

Abbott beats Nycomed and UCB in battle for Solvay’s drug unit

28-Sep-2009 - Abbott Laboratories will buy Solvay’s pharmaceutical unit for €4.8bn ($7bn) according to reports released earlier today.

News in brief

Camlin Fine Chemicals mulls API unit sale

28-Sep-2009 - The pharmaceutical division of Indian API maker Camlin Fine chemicals may be put up for sale by its parent company, stationary giant Camlin, after failing to expand.

News in brief

EC OKs Novartis’ move for Ebewe SP's injectables biz

24-Sep-2009 - The European Commission has approved Novartis’ €925m ($1.2bn) acquisition of Ebewe Spezial-Pharma’s generic injectables business.

Patheon overview - a look at what Lonza would gain

10-Sep-2009 - With Lonza and JLL competing over Patheon Outsourcing-Pharma looks at what the CMO offers to a prospective buyer, analysing its global manufacturing capacity and backlog using interactive maps and graphs.

News in brief

Galencia extends global reach with OM Pharma deal

08-Sep-2009 - Pharmaceutical manufacturer Galencia says its acquisition of Switzerland-based biotech group OM Pharma will bolster its international presence.

Cloud Packaging meets shorter run trend with Toll takeover

07-Sep-2009 - Cloud Packaging Solutions has said the acquisition of Toll Packaging will boost its ability to meet the increased demand for shorter packing runs triggered by the current global economic crisis.

News in brief

Dainippon to buy Sepracor for $2.6bn

03-Sep-2009 - Japanese drugmaker Dainippon Sumitomo Pharma (DSP) has entered into a definitive agreement to acquire US pharmaceutical group Sepracor for $2.6bn (€1.8bn).

Key Industry Events


Access all events listing

Our events, Events from partners...


Solid Lipid Excipients: Born to be Extruded !
Gattefossé Pharma
USP<233> Elemental Impurities Sample Prep Strategy
SGS Life Science Services
Online Cell Density Monitoring
Hamilton Bonaduz AG
Residual moisture in lyophilized pharmaceuticals
Metrohm – customized analysis for the pharmaceutical industry